Browsing Tag
LifeArc Ventures
1 post
AI-driven cancer drug discovery takes center stage as T-Cypher Bio advances T-cell engagers
T-Cypher Bio advances two cancer immunotherapies toward 2028 trials. Find out how the AI platform, investor backing and potential licensing opportunities are.